Reuters logo
BRIEF-Tianjin Zhongxin Pharmaceutical signs investment product agreement
November 29, 2016 / 10:25 AM / a year ago

BRIEF-Tianjin Zhongxin Pharmaceutical signs investment product agreement

Nov 29 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd

* Tianjin Zhongxin Pharmaceutical signed an investment product agreement with China Bohai Bank Co., Ltd., tianjin branch, with an investment of rmb200 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below